Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Antares Pharma Inc (ATRS)
Antares Pharma Inc (ATRS) News

ATRS

Antares Pharma (ATRS)

Antares Pharma Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ATRS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next >>

Date	Time	Source	Headline	Symbol	Company
07/02/2024	11:19AM	iHub Newswire	FeaturedBNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth
06/14/2019	5:32PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
06/14/2019	5:29PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
06/11/2019	5:45PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
06/11/2019	5:41PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
06/11/2019	5:38PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
06/11/2019	7:00AM	GlobeNewswire Inc.	Antares Pharma to Present at the Raymond James 2019 Life Sciences and MedTech Conference	NASDAQ:ATRS	Antares Pharma Inc
06/04/2019	5:15PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
06/04/2019	5:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
05/30/2019	7:00AM	GlobeNewswire Inc.	Antares Pharma to Present at the Jefferies 2019 Healthcare Conference	NASDAQ:ATRS	Antares Pharma Inc
05/16/2019	5:00PM	GlobeNewswire Inc.	Antares Pharma to Present at the B. Riley FBR Institutional Investor Conference	NASDAQ:ATRS	Antares Pharma Inc
05/03/2019	5:32PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
05/02/2019	4:33PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ATRS	Antares Pharma Inc
05/02/2019	7:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ATRS	Antares Pharma Inc
05/02/2019	7:00AM	GlobeNewswire Inc.	Antares Pharma Reports First Quarter 2019 Operating and Financial Results	NASDAQ:ATRS	Antares Pharma Inc
04/29/2019	6:03AM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ATRS	Antares Pharma Inc
04/26/2019	4:35PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ATRS	Antares Pharma Inc
04/18/2019	7:00AM	GlobeNewswire Inc.	Antares Pharma to Report First Quarter 2019 Financial and Operating Results	NASDAQ:ATRS	Antares Pharma Inc
04/10/2019	5:50PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
03/28/2019	7:30AM	GlobeNewswire Inc.	Antares Pharma Announces Receipt of Orphan Drug Designation for the Treatment of Ectopic Pregnancy With Methotrexate	NASDAQ:ATRS	Antares Pharma Inc
03/12/2019	5:15PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ATRS	Antares Pharma Inc
03/06/2019	7:00AM	GlobeNewswire Inc.	Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference	NASDAQ:ATRS	Antares Pharma Inc
03/05/2019	6:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
03/05/2019	5:57PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ATRS	Antares Pharma Inc
03/05/2019	10:04AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ATRS	Antares Pharma Inc
03/04/2019	10:34AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ATRS	Antares Pharma Inc
03/04/2019	7:00AM	GlobeNewswire Inc.	Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella	NASDAQ:ATRS	Antares Pharma Inc
02/28/2019	5:34PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
02/28/2019	7:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ATRS	Antares Pharma Inc
02/28/2019	7:00AM	GlobeNewswire Inc.	Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results	NASDAQ:ATRS	Antares Pharma Inc

Showing the most relevant articles for your search:NASDAQ:ATRS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next >>

New Momentum (PK)

Cann American (CE)

RespireRx Pharmaceuticals (PK)

Therapeutic Solutions (PK)

Elite Pharmaceuticals (QB)

Rennova Health (PK)

Asia Broadband (PK)

Bell Buckle (PK)

Progressive Care (QB)

Gold and GemStone Mining (PK)

Delayed Upgrade Clock